Neuromodulation News and Research

RSS
Spinal Modulation's Dorsal Root Ganglion Stimulation Pilot Clinical Trial results to be presented at 14th NANS

Spinal Modulation's Dorsal Root Ganglion Stimulation Pilot Clinical Trial results to be presented at 14th NANS

Palmetto GBA to cover PTNS therapy for patients with overactive bladder

Palmetto GBA to cover PTNS therapy for patients with overactive bladder

FDA clears Multi-Lead Trialing Cable for SCS therapy

FDA clears Multi-Lead Trialing Cable for SCS therapy

Boston Scientific announces first implantation of Vercise Deep Brain Stimulation System in Parkinson's disease trial

Boston Scientific announces first implantation of Vercise Deep Brain Stimulation System in Parkinson's disease trial

NICE issues PTNS guidance for overactive bladder

NICE issues PTNS guidance for overactive bladder

NMT releases new device for treatment of post-operative nausea

NMT releases new device for treatment of post-operative nausea

St. Jude Medical third quarter net sales increase 7% to $1.240 billion

St. Jude Medical third quarter net sales increase 7% to $1.240 billion

Early diagnosis of interstitial cystitis can improve quality of life

Early diagnosis of interstitial cystitis can improve quality of life

St. Jude Medical receives Japanese approval for Eon Mini spinal cord stimulation system

St. Jude Medical receives Japanese approval for Eon Mini spinal cord stimulation system

SCS, PNS prove to be effective tools in treating chronic pain: NANS, ASIPP

SCS, PNS prove to be effective tools in treating chronic pain: NANS, ASIPP

Study: PTNS offers an effective treatment option for detrusor overactivity incontinence

Study: PTNS offers an effective treatment option for detrusor overactivity incontinence

St. Jude Medical granted European CE Mark for Athena deep brain stimulation therapy management system

St. Jude Medical granted European CE Mark for Athena deep brain stimulation therapy management system

ONS trial results show promise for treating medically refractory chronic migraines: ONSTIM study

ONS trial results show promise for treating medically refractory chronic migraines: ONSTIM study

Medtronic Deep Brain Stimulation Therapy for severe epilepsy receives CE Mark approval

Medtronic Deep Brain Stimulation Therapy for severe epilepsy receives CE Mark approval

Medtronic 2011 first quarter revenue decreases 4%

Medtronic 2011 first quarter revenue decreases 4%

FDA approves two SCS leads for use with Boston Scientific's Precision Plus Spinal Cord Stimulator System

FDA approves two SCS leads for use with Boston Scientific's Precision Plus Spinal Cord Stimulator System

Medtronic launches Defeat-HF clinical trial to evaluate SCS for heart failure

Medtronic launches Defeat-HF clinical trial to evaluate SCS for heart failure

St. Jude Medical second-quarter net sales increase 11% to $1.313 billion

St. Jude Medical second-quarter net sales increase 11% to $1.313 billion

Uroplasty broadens neuromodulation patent portfolio

Uroplasty broadens neuromodulation patent portfolio

Boston Scientific launches SCS lead splitters for use with Precision Plus Spinal Cord Stimulator System

Boston Scientific launches SCS lead splitters for use with Precision Plus Spinal Cord Stimulator System